A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together produces a much stronger effect than using either one alone, suggesting a ...

Cystic fibrosis causes a buildup of mucus in the lungs that can lead to infection, and often death in children and young ...

Presence of cardiac fibrosis puts high-level endurance athletes at increased risk for ventricular tachycardia while ...

The facility is home to a pediatric cystic fibrosis program, which is the only CF center in Montana. This has been a game ...

Animate Biosciences today announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that ...

Multiple breath washout was done in 10% of Europeans with cystic fibrosis in 2023, mostly in children and in adults with near ...

Pulmonary fibrosis significantly impacts sexual function, with 74% of patients experiencing dyspnea during sexual activity, affecting their quality of life. The study used UCSD-SOBQ and SPARC ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...

This trial marks the first time that automated, quantitative high-resolution CT (HRCT) imaging biomarkers will serve as a ...

The global pulmonary fibrosis market is witnessing robust growth, driven by the rising prevalence of idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases, largely due to an aging ...